Freestone Grove Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,735	Closed	-$111K	–	673
2025 Q1	$111K	Sell	14,735 -15,578	-51%	-$117K	﹤0.01%	557
2024 Q4	$228K	Buy	+30,313	New	+$228K	﹤0.01%	516